The mRNA expression levels of these molecules (except vcam1) in the CP of APP−/− mESC-TEP-treated AD mice were higher than those in APP+/+ mESC-TEP-treated mice (Figure 6C). The gene discussed is CP; the disease is Alzheimer disease.